PTCT241115P40000
- 1.20
- 0.000.00%
PTC Therapeutics Newsroom
Express News | PTC Therapeutics Inc : RBC Raises Target Price to $39 From $34
PTC Therapeutics, Inc. (PTCT) Q3 2024 Earnings Call Transcript Summary
PTC Therapeutics, Inc. (PTCT) Q3 2024 Earnings Call Transcript
PTC Therapeutics: Strong Q3 Performance Amid Market and Regulatory Challenges, Holds Rating Amid Mixed Future Outlook
William Blair Maintains PTC Therapeutics(PTCT.US) With Buy Rating
William Blair Sticks to Its Buy Rating for PTC Therapeutics (PTCT)
PTC Therapeutics Raises Revenue Guidance for 2024
Express News | PTC Therapeutics Inc: Anticipates Total Revenues for Full Year 2024 to Be Between $750 Mln and $800 Mln
PTC Therapeutics | 10-Q: Quarterly report
PTC Therapeutics (PTCT) Reports Q3 Loss, Tops Revenue Estimates
PTC Therapeutics GAAP EPS of -$1.39 Beats by $0.13, Revenue of $196.78M Beats by $24.98M
Express News | PTC Therapeutics Provides Corporate Update and Reports Third Quarter 2024 Financial Results
Express News | PTC Therapeutics Q3 Product Revenue USD 135.421 Million
Express News | PTC Therapeutics Q3 Net Income USD -106.654 Million
Press Release: PTC Therapeutics Provides Corporate Update and Reports Third Quarter 2024 Financial Results
PTC Therapeutics 3Q Rev $196.8M >PTCT
Here Are the Major Earnings After the Close Today
Earnings Preview For PTC Therapeutics
PTC Therapeutics to Participate at Upcoming Investor Conferences
Earnings Preview: PTCT to Report Financial Results Post-market on November 07
$PTC Therapeutics(PTCT.US)$ is scheduled to release its financial results post-market on November 07 ET. Earnings PreviewAnalysts estimate $PTC Therapeutics(PTCT.US)$ to post revenue of USD171.80M